People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RayzeBio, Inc. | — | Biotechnology | Series D+ | $396.4M | $3.4B | 2020 |
| Ventus Therapeutics U.S., Inc. | — | Biotechnology | Series C | $186.8M | $1.6B | 2019 |
| Chinook Therapeutics U.S., Inc. | — | Biotechnology | Series D+ | $180.0M | $4.5B | 2019 |
| Graphite Bio, Inc. | — | Biotechnology | Series D+ | $150.7M | $4.9B | 2021 |
| Turnstone Biologics Corp. | — | Biotechnology | Series C | $122.1M | $2.2B | 2019 |
| Santa Ana Bio, Inc. | — | Biotechnology | Series B | $63.3M | $150.4M | 2021 |
| Tentarix Biotherapeutics, LP | — | Biotechnology | Series B | $43.0M | $358.2M | 2020 |
| Firefly Bio, Inc. | — | Biotechnology | Series B | $40.0M | $358.9M | 2023 |
| Mistral Therapeutics, Inc. | — | Biotechnology | Series B | $36.4M | $1.0B | 2018 |
| ChanRx Corp. | — | Pharmaceuticals | Series B | $22.1M | $563.6M | 2011 |
| Northern Mosaic LP | — | Biotechnology | Series A | $7.3M | $263.6M | 2019 |
| Inception IBD, Inc. | — | Pharmaceuticals | Series A | $6.9M | $214.3M | 2015 |
| Travus Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $750K | $41.4M | 2016 |
Jerel Davis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jerel Davis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| BRADLEY BOLZON | 3 | 10 |
| Srinivas Akkaraju | 2 | 10 |
| Clare Ozawa | 2 | 8 |
| Thomas Woiwode | 2 | 7 |
| Petpiboon Prasit | 2 | 7 |
| Jeremy Caldwell | 2 | 4 |
| Brendan Bulik-Sullivan | 2 | 2 |
| Rishi Gupta | 1 | 12 |
| Todd Foley | 1 | 12 |
| James Topper | 1 | 12 |
| Kevin Lalande | 1 | 8 |
| Carlo Rizzuto | 1 | 7 |
| Josh Resnick | 1 | 7 |
| Aaron Royston | 1 | 7 |
| Aaron Kantoff | 1 | 6 |
| Maha Katabi | 1 | 6 |
| PAUL Grayson | 1 | 5 |
| Bradley J. Bolzon | 1 | 5 |
| Hao Wu | 1 | 5 |
| John Finn | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.